Home › Celgene's Pending Sanctions Motions against Kyle Bass's Hedge Fund
 

Keywords :   


Celgene's Pending Sanctions Motions against Kyle Bass's Hedge Fund

2015-08-27 05:51:32| Biotech - Topix.net

The Patent Trial and Appeals Board previously authorized Celgene Corporation to move for sanctions against the Coalition for Affordable Drugs , an entity affiliated with a Kyle Bass hedge fund that had filed several inter partes review petitions against Celgene and other biotech companies. As expected, Celgene's recently filed motion focuses on the Coalition's underlying goal of "profit[ing] by affecting stock prices."

Tags: fund pending kyle sanctions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Weekly Recap: Huggies Launches Skin Essentials Diaper, P&G Recognizes Key Suppliers & More
12.05California Bill Limits Skincare Sales to Teens & Persil Rebrands
12.05Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05Glo30 Starts 2024 Strong with 60% Growth
12.05Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05L\'Oréals Brand Value Soars to $13.4 Billion
12.05Spate Unveils the Top Sustainability Trends Cycling Google Searches
12.05Oh K! is the Most Searched Beauty Brand in the World: Cosmetify
More »